🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Kangaroo Care on Test Weighing

RecruitingNAAges 32 Weeks - 40 WeeksAllIstanbul University - Cerrahpasa
NCT04252547 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study will be conducted with the Crossover Randomized Controlled Method. The infants who have attained oral feeding in the neonatal intensive care unit will be divided into two groups via randomization in the computer environment. After the randomization, kangaroo care will be applied to the infants in Group 1 during the first feeding hour when they are included in the study and they will be breastfed by their mothers without any other application during the next feeding. On the other hand, no application will be performed on the infants in Group 2 during the first feeding hour when they are included in the study and kangaroo care will be applied to them during the second feeding hour. The infants in both groups will be breastfed by their mothers during the feeding hours.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: \- Agreeing to participate in the study for parents. The inclusion criteria for infants were as follows; * Attaining to oral feeding by the physician in the neonatal intensive care unit * Being born at 26-36+6 gestational week which is determined according to the mother's last period cycle * Being at 32-39+6 postmenstrual week during the time they are included in the study * Having body weight of 1500 grams and above * Being breastfed at least once * Having no health problems other than being preterm Exclusion Criteria: The exclusion criteria for infants were as follows; * Suffering from gastrointestinal, neurological or genetic diseases (such as necrotizing enterocolitis, intracranial bleeding, hydrocephalia, omphalocele, down syndrome, gastroschisis) and other diseases * Having a condition obstructing oral feeding (such as cleft palate, cleft lip, facial muscle paralysis, craniofacial abnormalities etc.) * Receiving oxygen support
💊

What it tests

  • Kangaroo Care
  • Control
📍

Where

1 site
Istanbul Medipol University
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy